Central corticotropin-releasing factor (CRF) may attenuate somatic pain sensitivity through involvement of glucocorticoids.

Yarushkina, N I; Bagaeva, T R; Filaretova, L P

Yarushkina, N I; Bagaeva, T R; Filaretova, L P.

Affiliation

Yarushkina NI; Laboratory of Experimental Endocrinology, Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia. yarni60@mail.ru

J Physiol Pharmacol ; 62(5): 541-8, 2011 Oct.

Article in En | MEDLINE | ID: mdl-22204802

Subject(s)

Analgesics, Non-Narcotic/therapeutic use; Corticotropin-Releasing Hormone/therapeutic use; Glucocorticoids/blood; Nociceptive Pain/drug therapy; Pain Threshold/drug effects; Analgesics, Non-Narcotic/administration & dosage; Animals; Corticosterone/blood; Corticotropin-Releasing Hormone/pharmacology; Electric Stimulation; Injections, Intraventricular; Male; Mifepristone/pharmacology; Naltrexone/pharmacology; Narcotic Antagonists; Nociceptive Pain/blood; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Corticotropin-Releasing Hormone / Pain Threshold / Analgesics, Non-Narcotic / Nociceptive Pain / Glucocorticoids Type of study: Diagnostic_studies Limits: Animals Language: En Journal: J Physiol Pharmacol Journal subject: FARMACOLOGIA / FISIOLOGIA Year: 2011 Document type: Article Affiliation country: RUSSIA Country of publication: Poland

Search on Google

Add to My VHL

XML

PubMed Links